AdvtAdvtJoin the community of 2M+ industry professionals Subscribe to our newsletter to get latest insights & analysis. Enter Email Download ETHealthworld App Get Realtime updatesSave your favourite articles Scan to download AppChandigarh : Pharma major Venus Remedies Ltd on Tuesday said it has further consolidated its position in the oncology space with marketing authorisation from Philippines and Iraq for two more widely used cancer drugs. While Venus Remedies has secured marketing approval for bleomycin from Philippines , the second largest market in the Association of Southeast Asian Nations ASEAN ) region, it has entered the Iraq market for the first time with a product registration for gemcitabine, the Panchkula-based company said in a statement.Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd dubbed it as a decisive step towards achieving the company's goal of emerging as the top oncology medicine supplier from India in the ASEAN region and further expanding the reach of its oncology products in the Middle East and North Africa (MENA) market. "These marketing approvals from Philippines and Iraq will enable us to not only enhance our global reach, but also provide access to life-saving treatment to more and more patients in line with our focus area of meeting unmet medical needs in oncology and other critical-care segments," said Chaudhary.The USD 5-billion pharmaceutical market of Philippines, a growing market for cancer drugs, where Venus Remedies has so far secured marketing approval for 37 products across various segments, presents immense opportunities to expand its operations in the Asia-Pacific region in general and Southeast Asia in particular. "While we have more than 140 marketing authorisations in the ASEAN region, including 110 for oncology drugs, we are banking on the product registration for bleomycin from the Philippines to pave the way for faster approval of this drug in other ASEAN countries," said Chaudhary.Venus Remedies has already submitted dossiers to the health ministry of the Philippines government for another 50-odd marketing authorisations.

Source: The North Africa Journal May 09, 2023 21:04 UTC